These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9534026)

  • 1. Subclinical thyrotoxicosis.
    Marqusee E; Haden ST; Utiger RD
    Endocrinol Metab Clin North Am; 1998 Mar; 27(1):37-49. PubMed ID: 9534026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current issues in the treatment of thyrotoxicosis].
    Papi G
    Recenti Prog Med; 2005 Nov; 96(11):560-5. PubMed ID: 16499167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical and therapeutic approach to thyrotoxicosis with thyroid-stimulating hormone suppression only.
    Papi G; Pearce EN; Braverman LE; Betterle C; Roti E
    Am J Med; 2005 Apr; 118(4):349-61. PubMed ID: 15808130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The many causes of subclinical hyperthyroidism.
    Charkes ND
    Thyroid; 1996 Oct; 6(5):391-6. PubMed ID: 8936661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
    Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of pyridostigmine on the thyrotropin response to thyrotropin-releasing hormone in endogenous depression and subclinical thyrotoxicosis.
    Coiro V; Volpi R; Marchesi C; DeFerri A; Capretti L; Caffarri G; Colla R; Chiodera P
    Metabolism; 1998 Jan; 47(1):50-3. PubMed ID: 9440477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical evaluation of patients with subclinical hyperthyroidism and free triiodothyronine (free T3) toxicosis.
    Figge J; Leinung M; Goodman AD; Izquierdo R; Mydosh T; Gates S; Line B; Lee DW
    Am J Med; 1994 Mar; 96(3):229-34. PubMed ID: 8154510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical Graves' disease as a cause of subnormal TSH levels in euthyroid subjects.
    Kasagi K; Takeuchi R; Misaki T; Kousaka T; Miyamoto S; Iida Y; Konishi J
    J Endocrinol Invest; 1997 Apr; 20(4):183-8. PubMed ID: 9211123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing thyrotoxicosis in the acute medical setting.
    Napier C
    Acute Med; 2018; 17(1):44-48. PubMed ID: 29589605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.
    Sato K; Miyakawa M; Eto M; Inaba T; Matsuda N; Shiga T; Ohnishi S; Kasanuki H
    Endocr J; 1999 Jun; 46(3):443-51. PubMed ID: 10503998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid function and prevalence of anti-thyroperoxidase (TPO) and anti-thyroglobulin (Tg) antibodies in outpatients hospital setting in an area with sufficient iodine intake: influences of age and sex.
    Legakis I; Manousaki M; Detsi S; Nikita D
    Acta Med Iran; 2013; 51(1):25-34. PubMed ID: 23456581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observations concerning the natural history of subclinical hyperthyroidism.
    Woeber KA
    Thyroid; 2005 Jul; 15(7):687-91. PubMed ID: 16053385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthyroidism.
    Maji D
    J Indian Med Assoc; 2006 Oct; 104(10):563-4, 566-7. PubMed ID: 17380820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: a population-based study.
    Carlé A; Knudsen N; Pedersen IB; Perrild H; Ovesen L; Rasmussen LB; Laurberg P
    Eur J Endocrinol; 2013 Nov; 169(5):537-45. PubMed ID: 23935127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotoxicosis.
    Kannan CR; Seshadri KG
    Dis Mon; 1997 Sep; 43(9):601-77. PubMed ID: 9301645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical thyrotoxicosis.
    Al-Abadi AC
    Postgrad Med J; 2001 Jan; 77(903):29-32. PubMed ID: 11123391
    [No Abstract]   [Full Text] [Related]  

  • 17. Audit of hyperthyroxinaemia and thyrotoxicosis using a sensitive TSH assay.
    O'Hare J; Abuaisha B; Barrett E
    Ir Med J; 1991 Jun; 84(2):70-2. PubMed ID: 1910022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC; Ingbar SH
    J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of amiodarone-iodine-induced thyrotoxicosis(AIIT) associated with severe nonthyroidal illness.
    Balzano S; Sau F; Bartalena L; Ruscazio M; Balestrieri A; Cherchi A; Martino E
    J Endocrinol Invest; 1987 Dec; 10(6):589-91. PubMed ID: 3440824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of thyroid status in patients with thyrotoxicosis.
    Braverman LE
    Clin Chem; 1996 Jan; 42(1):174-8. PubMed ID: 8565222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.